Melissa Merritt to Risk
This is a "connection" page, showing publications Melissa Merritt has written about Risk.
Connection Strength
0.483
-
Merritt MA, Riboli E, Weiderpass E, Tsilidis KK, Overvad K, Tj?nneland A, Hansen L, Dossus L, Fagherazzi G, Baglietto L, Fortner RT, Ose J, Steffen A, Boeing H, Trichopoulou A, Trichopoulos D, Lagiou P, Masala G, Sieri S, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Hjart?ker A, Gram IT, Quir?s JR, Ob?n-Santacana M, Molina-Montes E, Huerta Casta?o JM, Ardanaz E, Chamosa S, Sonestedt E, Idahl A, Lundin E, Khaw KT, Wareham N, Travis RC, Rinaldi S, Romieu I, Chajes V, Gunter MJ. Dietary fat intake and risk of epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol. 2014 Oct; 38(5):528-37.
Score: 0.116
-
Merritt MA, Cramer DW, Vitonis AF, Titus LJ, Terry KL. Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes. Int J Cancer. 2013 Mar 01; 132(5):1114-24.
Score: 0.101
-
Merritt MA, Kotsopoulos J, Cramer DW, Hankinson SE, Terry KL, Tworoger SS. Duarte galactose-1-phosphate uridyl transferase genotypes are not associated with ovarian cancer risk. Fertil Steril. 2012 Sep; 98(3):687-91.
Score: 0.100
-
Peres LC, Mallen AR, Townsend MK, Poole EM, Trabert B, Allen NE, Arslan AA, Dossus L, Fortner RT, Gram IT, Hartge P, Idahl A, Kaaks R, Kvaskoff M, Magliocco AM, Merritt MA, Quir?s JR, Tjonneland A, Trichopoulou A, Tumino R, van Gils CH, Visvanathan K, Wentzensen N, Zeleniuch-Jacquotte A, Tworoger SS. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium. Cancer Res. 2019 10 15; 79(20):5442-5451.
Score: 0.041
-
Fortner RT, H?sing A, K?hn T, Konar M, Overvad K, Tj?nneland A, Hansen L, Boutron-Ruault MC, Severi G, Fournier A, Boeing H, Trichopoulou A, Benetou V, Orfanos P, Masala G, Agnoli C, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Gram IT, Gavrilyuk O, Quir?s JR, Maria Huerta J, Ardanaz E, Larra?aga N, Lujan-Barroso L, S?nchez-Cantalejo E, Butt ST, Borgquist S, Idahl A, Lundin E, Khaw KT, Allen NE, Rinaldi S, Dossus L, Gunter M, Merritt MA, Tzoulaki I, Riboli E, Kaaks R. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort. Int J Cancer. 2017 03 15; 140(6):1317-1323.
Score: 0.035
-
Roura E, Travier N, Waterboer T, de Sanjos? S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tj?nneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno-de-Mesquita HB, Quir?s JR, S?nchez MJ, Navarro C, Barricarte A, Larra?aga N, Ekstr?m J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E, Castellsagu? X. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One. 2016; 11(1):e0147029.
Score: 0.032
-
Ob?n-Santacana M, Freisling H, Peeters PH, Lujan-Barroso L, Ferrari P, Boutron-Ruault MC, Mesrine S, Baglietto L, Turzanski-Fortner R, Katzke VA, Boeing H, Quir?s JR, Molina-Portillo E, Larra?aga N, Chirlaque MD, Barricarte A, Khaw KT, Wareham N, Travis RC, Merritt MA, Gunter MJ, Trichopoulou A, Lagiou P, Naska A, Palli D, Sieri S, Tumino R, Fiano V, Galassom R, Bueno-de-Mesquita HB, Onland-Moret NC, Idahl A, Lundin E, Weiderpass E, Vesper H, Riboli E, Duell EJ. Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort. Int J Cancer. 2016 Mar 01; 138(5):1129-38.
Score: 0.031
-
Kaaks R, Tikk K, Sookthai D, Schock H, Johnson T, Tj?nneland A, Olsen A, Overvad K, Clavel-Chapelon F, Dossus L, Baglietto L, Rinaldi S, Chajes V, Romieu I, Boeing H, Sch?tze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Ricceri F, Mattiello A, Buckland G, Ram?n Quir?s J, S?nchez MJ, Amiano P, Chirlaque MD, Barricarte A, Bas Bueno-de-Mesquita H, van Gils CH, Peeters PH, Andersson A, Sund M, Weiderpass E, Khaw KT, Wareham N, Key TJ, Travis RC, Merritt MA, Gunter MJ, Riboli E, Lukanova A. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort. Int J Cancer. 2014 Apr 15; 134(8):1947-57.
Score: 0.027